Actimmune and Cellulitis - a phase IV clinical study of FDA data

Summary:

Cellulitis is reported as a side effect among people who take Actimmune (interferon gamma-1b), especially for people who are male, 40-49 old, have been taking the drug for 6 - 12 months also take Infergen, and have Chronic granulomatous disease.

The phase IV clinical study analyzes which people have Cellulitis when taking Actimmune. It is created by eHealthMe based on reports of 1,728 people who have side effects when taking Actimmune from the FDA, and is updated regularly.

What is Actimmune?

Actimmune has active ingredients of interferon gamma-1b. eHealthMe is studying from 1,734 Actimmune users. Check the latest studies of Actimmune.

What is Cellulitis?

Cellulitis (infection under the skin) is found to be associated with 2,110 drugs and 2,337 conditions by eHealthMe. Check the latest studies of Cellulitis.

On Jun, 18, 2026

1,728 people reported to have side effects when taking Actimmune.
Among them, 11 people (0.64%) have Cellulitis.

Among these 11 people:

How long have people been on Actimmune when they have Cellulitis? *

What is the gender of people who have Cellulitis when taking Actimmune? *

female: 18.18 %
male: 81.82 %

What is the age of people who have Cellulitis when taking Actimmune? *

What are other drugs people take besides Actimmune? *

What are other side effects people have besides Cellulitis? *

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 3 people, 27.27%
Anaemia (lack of blood): 3 people, 27.27%
Fever: 3 people, 27.27%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 18.18%
Diabetes Mellitus Non Insulin-Dependent: 2 people, 18.18%
Obstructive Sleep Apnea Syndrome (a sleep disorder that involves cessation or significant decrease in airflow in the presence of breathing effort): 2 people, 18.18%
Fall: 2 people, 18.18%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 18.18%
High Blood Pressure: 2 people, 18.18%
Pulmonary Embolism (blockage of the main artery of the lung): 2 people, 18.18%

What are the existing conditions these people have? *

Chronic Granulomatous Disease (immune system cells are unable to kill some types of bacteria and fungi): 5 people, 45.45%
Hepatitis C: 4 people, 36.36%

* Approximation only. Some reports may have incomplete information.

Do you take Actimmune and have Cellulitis?

- Check whether Cellulitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Actimmune:

Actimmune (1,734 reports)

Cellulitis treatments and more:

Cellulitis (75,290 reports)

Browse all side effects of Actimmune:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cellulitis:

Cellulitis (2,110 drugs)

Browse all the conditions that are associated with Cellulitis:

Cellulitis (2,337 conditions)

Related publications that referenced our studies

Yaylaci S, Yilmaz EU, Guclu E, Kumsar NA, Tamer A, Karabay O, "Clozapine-Induced Febrile Neutropenia and Cellulitis", Turkish journal of emergency medicine, 2014 Mar .
Yaylaci S, Yilmaz EU, Guclu E, Kumsar NA, Tamer A, Karabay O, "Clozapine-Induced Febrile Neutropenia and Cellulitis", Turkish journal of emergency medicine, 2014 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on interferon gamma-1b (the active ingredients of Actimmune) and Actimmune (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.